A Research on Contrast-enhanced Ultrasound and Detection of Human Mammaglobin Gene in Axilla Lymph Node of Breast Masses

WANG Qian,MI Cheng-rong,WANG Wen
DOI: https://doi.org/10.3969/j.issn.1674-6309.2011.05.011
2011-01-01
Abstract:Objective To evaluate the clinical value of SonoVue in sentinel lymphatic node(SLN) in patients with breast masses by analyzing the enhanced phase of axillary lymph node(ALN) after subcutaneous injection SonoVue and detecting the expression of human mammaglobin(hMAM) in ALN of human breast masses.Methods 21 cases with breast masses were injected subcutaneously with contrast agent and Methylene blue successively to the same position of borderline of breast tumor.The enhanced phases of ipsilateral ALN were observed.The all SLNs were marked preoperatively and were examined with routine pathological and hMAM of reverse transcription-polymerase chain reaction(RT-PCR)test postoperatively.Results 15 patients were detected SLN after angiography,the success rate was 71.4%(15/21).19 cases detected SLN after methylene blue,the detection rate was 90.5%(19/21).No significant difference of detection between the two methods was found;49 SLNs were detected(benign 11;malignant 38),pathology showed that 26 of malignant masses was transfered and the accuracy was 75.5%(37/49).RT-PCR showed 37 was positive and the accuracy was 97.9%(48/49).A significant difference between the two methods was found.Conclusion The subcutaneous injection SonoVue is effective to detection of SLN in patients with breast cancer and differentiation the benign and malignant;RT-PCR for hMAMmRNA test can significantly increase the detection rate of metastasis SLN with breast cancer.
What problem does this paper attempt to address?